>
pdufa.bio

PI-2620

Updated ยทnext FDA decision on the calendar

PI-2620 is a Lantheus Holdings Inc. program. Its next catalyst is a Readout in Jun 2027. Every date links its source.

LNTH catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Lantheus Holdings Inc. (LNTH). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Jun 2027LNTH

Questions

When is PI-2620's next FDA decision or readout?

The next tracked catalyst for PI-2620 is a Readout in Jun 2027.

What happened at PI-2620's most recent FDA decision?

No FDA decision for PI-2620 is in our archive yet.

Who makes PI-2620?

Lantheus Holdings Inc. (LNTH).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.